Alkem Laboratories Limited (NSE:ALKEM)

India · Delayed Price · Currency is INR

5,566.00

-73.50 (-1.30%)

At close: Mar 2, 2026

Revenue by Segment

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020	Mar '19 Mar 31, 2019	Mar '18 Mar 31, 2018	Mar '17 Mar 31, 2017	Mar '16 Mar 31, 2016
Pharmaceuticals	129.65B	126.68B	115.99B	106.34B	88.65B
Pharmaceuticals Growth	2.34%	9.21%	9.08%	19.96%	6.24%
Total	129.65B	126.68B	115.99B	106.34B	88.65B
Total Growth	2.34%	9.21%	9.08%	19.96%	6.24%

Revenue by Geography

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020	Mar '19 Mar 31, 2019	Mar '18 Mar 31, 2018	Mar '17 Mar 31, 2017	Mar '16 Mar 31, 2016
India	91.44B	86.62B	81.60B	75.27B	58.21B
India Growth	5.56%	6.15%	8.41%	29.30%	3.83%
United States (US)	24.82B	27.71B	25.13B	23.29B	24.67B
United States (US) Growth	-10.44%	10.25%	7.91%	-5.57%	12.12%
Other International	13.39B	12.35B	9.26B	7.78B	5.78B
Other International Growth	8.47%	33.34%	18.94%	34.78%	7.31%
Total	129.65B	126.68B	115.99B	106.34B	88.65B
Total Growth	2.34%	9.21%	9.08%	19.96%	6.24%

Source: S&P Global Market Intelligence.